Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page
- CheckyesterdayChange DetectedKharkiv Oblast is now listed with standardized spelling, and a city-level location for Kharkiv, Kharkiv Oblast, Ukraine, 61103 has been added, replacing the previous Kharkivs’ka Oblast’ spelling and its associated entry.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page display now reflects a new revision label (v3.5.4), indicating a page build update rather than a change to the study details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s revision/version label in the footer has been updated from v3.5.2 to v3.5.3, reflecting a technical/site update rather than a change to the study information.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Araucania and Temuco, Araucania, Chile, 4800827. Added Bucharest; updated Temuco, Región de la Araucanía, Chile, 4800827 to Temuco, Araucania, Chile, 4800827 and București to Bucharest; revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check73 days agoChange DetectedNapoli, Italy 80131 was replaced with Naples, Italy 80131 in the location list, and the revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check81 days agoChange DetectedThe study status was updated to Completed with a completion date of 2026-01-20; the previous Active, not recruiting status was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.